Ezetimibe/Simvastatin Label Revision
The product label for generic ezetimibe/ medication simvastatin (Vytorin drug, Merck/Schering-Plough) may now show that it was more effective than generic rosuvastatin calcium (Crestor, AstraZeneca) in lowering low-density lipoprotein-cholesterol levels at all doses that were compared. In a study of 2,959 patients, high cholesterol levels were reduced by 52% to 61% with Vytorin 10/20 to 10/80 mg and by 46% to 57% with Generic Crestor 10 to 40 mg. Both drugs raised high-density lipoprotein-choles-terol by 8°%.
